Noninvasive urine-based tests to diagnose or detect recurrence of bladder cancer

28Citations
Citations of this article
45Readers
Mendeley users who have this article in their library.

Abstract

Liquid biopsies are increasingly used for the diagnosis and follow-up of cancer patients. Urine is a body fluid that can be used to detect cancers and others diseases. It is noninvasive and easy to collect. To detect Bladder Cancer (BC), cytology is the first assay used. It is an effective way to detect high grade BC but has a high rate of equivocal results, especially for low grade BC. Furthermore, cystoscopy is used to confirm cytology results and to determine cancer status. Cystoscopy is also effective but highly invasive, and not well accepted by patients, especially for BC follow-up. In this review we survey the numerous assays recently developed in order to diagnose BC at an early stage, and to facilitate the follow-up of patients. We discuss their effectiveness, ease of use, and applications. Finally, we discuss assays that, in the future, could improve the diagnosis and management of BC patients.

Cite

CITATION STYLE

APA

Charpentier, M., Gutierrez, C., Guillaudeux, T., Verhoest, G., & Pedeux, R. (2021, April 1). Noninvasive urine-based tests to diagnose or detect recurrence of bladder cancer. Cancers. MDPI AG. https://doi.org/10.3390/cancers13071650

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free